Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV.
about
New developments in the management of moderate-to-severe hemophilia BAnimal models of hemophiliaCurrent animal models of hemophilia: the state of the artOnce-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia BExtravascular FIX and coagulationCrosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesPlatelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis.Animal models of hemophilia and related bleeding disorders.Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system.Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice.Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.Collagen-mediated hemostasis.Factor IX binding to collagen.Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants.Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy.Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.An update on factor XI structure and function.
P2860
Q26751323-BE04CBD3-8DB2-46FD-A528-7DB5B1A3CBF5Q27012571-935BE012-985C-46CE-A914-7A9EB5989CF0Q28072423-8A69B6B4-59CF-45A1-826A-0AF27479BE99Q28078281-8B50B549-E6D8-4DFC-9290-37236D9A074AQ28079369-55233333-389D-47C5-B8B0-BC4747859C74Q33403517-A265973D-B673-4CF4-ABF0-CFBC5CAB556EQ33432917-AAB45DB8-62B5-4534-9BC7-CDFDA762AA55Q35078437-A2BAC621-A9AF-4A0A-ACE5-332368AAB330Q36325536-6FB5B172-DD36-444D-9298-1D5262CA9576Q37091290-2329C83B-A163-4B0C-82D7-67C860FEE726Q37330601-1B264F1A-73F4-4872-BA1F-C08C565BDA99Q37623821-10DC06C9-D34E-4C84-BE77-897D0204B620Q37634856-84DDD5E7-947C-454F-9D85-CDAD50CC1DC0Q38691485-3F7B2BF1-5B6F-4B5C-A32F-6534D124864BQ40124164-64FEFCD1-431E-4327-A484-C3565205596FQ42228305-A40ADA20-A131-43B8-9C0A-25E9448EC43FQ42386221-BF5E1D17-6FD8-426F-AE90-BA7B0814AEE8Q42544183-80587C96-10AD-46C9-BBB1-AD7AD26845C7Q45868456-62634E20-1470-4622-99F4-FB13E21520CEQ45874726-A9CAF33F-14A8-4673-B46A-2C72FF3C705BQ47311661-956E1504-1A0D-4369-AF06-B185BC8235E4
P2860
Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@ast
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@en
type
label
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@ast
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@en
prefLabel
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@ast
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@en
P2093
P1476
Abnormal hemostasis in a knock ...... d binding to collagen type IV.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2009.03545.X
P577
2009-07-06T00:00:00Z